Loading...
•
Dec 31, 2019
Teladoc Q4 2019 Earnings Report
Teladoc Health reported a 27% increase in Q4 revenue to $156.5 million and a 44% increase in total visits to 1.2 million, demonstrating strong performance.
Key Takeaways
Teladoc Health reported strong Q4 2019 results, with revenue increasing by 27% year-over-year to $156.5 million and total visits increasing by 44% to 1.2 million. The company's diversified growth strategies are driving strong growth across its channels.
Q4 revenue increased 27% year-over-year to $156.5 million.
Total visits increased 44% year-over-year to 1.2 million.
Net loss was $(19.0) million for the fourth quarter 2019 compared to $(24.9) million for the fourth quarter 2018.
Net loss per basic and diluted share was $(0.26) for the fourth quarter 2019 compared to $(0.35) for the fourth quarter 2018.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the first-quarter 2020, Teladoc Health expects total revenue to be in the range of $169 million to $172 million and total visits to be between 1.4 million and 1.6 million.
Positive Outlook
- Total revenue to be in the range of $169 million to $172 million.
- EBITDA loss to be in the range of $(9) million to $(7) million.
- Adjusted EBITDA to be in the range of $9 million to $11 million.
- Total U.S. paid membership to be approximately 40 million to 41 million members and visit-fee-only access to be available to approximately 19.2 million individuals.
- Total visits to be between 1.4 million and 1.6 million.
Challenges Ahead
- Net loss per share, based on 73.1 million weighted average shares outstanding, to be between $(0.37) and $(0.34).
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...